中文 | English
Return
Total: 85 , 1/9
Show Home Prev Next End page: GO
Author:(Gaofeng XU)

1.Comparison of the efficacy and safety of the different doses of rivaroxaban in treatment of left ventricular apical thrombus

Gaofeng XU

Chinese Journal of Primary Medicine and Pharmacy 2016;23(21):3272-3275,3276

2.Iatrogenic subclavian artery pseudoaneurysm close to the origin of the vertebral artery: an endovascular strategy

Gaofeng XU

Journal of Interventional Radiology 2006;15(7):445-448

3.Anticoagulantion of Ischemic Cerebrovascular Diseases

Anding XU ; Gaofeng ZHOU

International Journal of Cerebrovascular Diseases 2006;0(04):-

4.EFFECTS OF Se ON MONOAMINE OXIDASE ACTIVITY

Lanhua ZHOU ; Gaofeng FAN ; Guanglu XU

Journal of Xi'an Jiaotong University(Medical Sciences) 1982;0(01):-

5.Prognostic significance of left ventricular systolic function in acute coronary syndrome patients treated with PCI

Gaofeng ZHANG ; Peng XU ; Xusheng WU

Chinese Journal of Interventional Cardiology 2003;0(05):-

7.Study on mental health of Chinese standby peacekeeping troops and its related influencing factors

Liyi ZHANG ; Zhixiong XU ; Lianlian XU ; Chunxia CHEN ; Gaofeng YAO

Medical Journal of Chinese People's Liberation Army 2001;0(09):-

8.Application of objective structured clinical examination in assessment of interns of traditional Chinese medicine in anesthesiology department

Gaofeng ZHAO ; Jianwei WU ; Shaoqun XU ; Weixian ZHAO

Chinese Journal of Medical Education Research 2013;(8):793-795,796

9.Continuous infusion of propofol combined with midazolam for patients undergoing long-time microsurgeries

Gaofeng ZHANG ; Gang LI ; Yongguang XU ; Xianling CHENG

Basic & Clinical Medicine 2006;0(07):-

10.Selective COX-2 inhibitor Celecoxib prevents postoperative abdominal adhesion

Kang WANG ; Xuqi LI ; Guangbing WEI ; Xin XU ; Gaofeng PING

Journal of Xi'an Jiaotong University(Medical Sciences) 2010;31(2):217-220

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 85 , 1/9 Show Home Prev Next End page: GO